CoreAge Rx is our recommended featured care option. Its NAD+ pages give readers two separately described formats to examine: a nasal spray and an injectable product. The first useful step is to read the exact page, rather than treating “recovery” as a single defined medical outcome.
This review examines the provider’s published menu and access process, checked on October 3, 2026. We have not used the products, tested their contents, audited the pharmacy, or measured patient outcomes. The pages’ benefit descriptions remain provider claims unless independently established for the exact product and use.
Two formats, two questions to confirm
The nasal and injectable pages each display a starting price of $93 per month. Both describe an online questionnaire, clinician review, and delivery if a prescription is granted. A starting figure is a public offer to investigate, not a personal quote or a guarantee of approval.
Ask which product is proposed, what the exact formulation and pharmacy are, what the payment includes, and how follow-up works. A nasal format and an injectable format should not be assumed interchangeable. Follow the prescriber’s product-specific directions rather than a general article or promotional timeline.
Keep the recovery language in its proper place
The product pages discuss energy, focus, aging, and recovery. Those descriptions do not establish that the products treat insomnia or explain a reader’s daytime fatigue. We do not repeat the pages’ dosing examples, expected-results timelines, or broad safety claims as instructions or independently proven outcomes.
For persistent sleep trouble or unusual tiredness, use a care route that can evaluate the actual concern. The sleep-care guide helps prepare that conversation. A product menu can answer what a provider offers; it cannot diagnose why you are not feeling rested.
Source: CoreAge Rx: NAD+ Injectable product page ↗
Keep reading: What to bring to a conversation about sleep →Compounding is an important distinction
CoreAge describes these products as compounded in the United States. FDA explains that compounded drugs are not FDA approved and that the agency does not verify their safety, effectiveness, or quality before marketing. Compounding can serve a patient need, but it should not be described as FDA approval for the finished product.
Ask the provider about the dispensing pharmacy, formulation, storage, labeling, and the contact route for a product concern. The source review does not establish that a particular pharmacy or transaction complies with every applicable requirement. Those details need confirmation through the actual care process.
Source: FDA: Risks of Compounded Drugs ↗
Compare the service you actually need
CoreAge has first featured placement through this publication’s commercial relationship, explained in the footer and editorial policy. That recommendation is not a clinical finding that NAD+ is superior to sleep treatment, an app, or another care route. These options do different jobs.
The Headspace and Calm reviews cover listening services, while the journal and planner are free organizational tools. If you choose to investigate CoreAge, open the current product page and ask for the exact care and payment terms. If your question is about a sleep disorder, keep that question with a qualified professional.
Keep reading: Headspace sleepcasts review: a landscape you can listen to →Sources and reading
Primary sources retained through TinyFish. A check date is when we read a page, not a claim that every source was newly published. No clinical reviewer is represented.